(Q83365542)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708355%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Mononuclear cell infiltration in clear-cell renal cell carcinoma independently predicts patient survival (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708355%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708355%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

W Scott Webster

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708355%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Christine M Lohse

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708355%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

R Houston Thompson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708355%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Haidong Dong

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708355%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Xavier Frigola

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708355%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Demetrius L Dicks

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708355%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Igor Frank

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708355%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Bradley C Leibovich

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708355%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Michael L Blute

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708355%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

John C Cheville

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708355%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Eugene D Kwon

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708355%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

1 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708355%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708355%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708355%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708355%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

46-53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708355%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

cites work

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

Improved prognostication of renal cell carcinoma using an integrated staging system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

Chemotherapeutic strategies for renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

Clinical responses following nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma are associated with expansion of CD8+ IFN-gamma-producing T cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

Allogeneic stem cell transplantation for renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

Investigating the potential of bevacizumab in other indications: metastatic renal cell, non-small cell lung, pancreatic and breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

Effect of tumor-infiltrating lymphocyte subsets on prognosis and susceptibility to interferon therapy in patients with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

Prognostic histological and immune markers of renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

Prognostic significance of the Heidelberg classification of renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

Cytokines and immune response in the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

The great escape: Is immune evasion required for tumor progression?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

The central role of CD4(+) T cells in the antitumor immune response

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

Stat3 activity in melanoma cells affects migration of immune effector cells and nitric oxide-mediated antitumor effects

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

Nitric oxide and the immune response

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

Regulatory T cells and mechanisms of immune system control

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21951

7 January 2021

Identifiers

DOI

10.1002/CNCR.21951

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708355%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference